Low-dose angiotensin AT1 receptor β-arrestin-biased ligand, TRV027, protects against cisplatin-induced nephrotoxicity.
Abdolhamid EsmaeeliFatemeh EbrahimiKaveh TanhaMajid AssadiMohammad SeyedabadiPublished in: Pharmacological reports : PR (2020)
Low-dose TRV027 may offer potential benefits in kidney injury due to cisplatin.